Human Insulin Industry, January 2015 Market Reports from Top Publishers

You might be interested in: insulin, biosimilar, therapeutics.


 
1-10 of 18 reports for Human Insulin

Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Infection. It has completed phases i and ii studies of the formulation of fast-acting human insulin, phases i and ii studies of an ultra-fast acting insulin lispro and phase i/ii on a unique combination of insulin ...

2015 Deep Research Report on Global Recombinant Human Insulin Industry

2015 Deep Research Report on Global Recombinant Human Insulin Industry

  • $ 2 600
  • Industry report
  • January 2015
  • by QY Research Group

... Recombinant human insulin supply import export consumption 20chapter five recombinant human insulin manufacturing process and cost structure 215.1 Recombinant human insulin product specifications 21 ...

Tonghua Dongbao Pharmaceutical Co., Ltd. (Symbol:600867) SWOT Analysis, Strategy, Revenues and Profits

Tonghua Dongbao Pharmaceutical Co., Ltd. (Symbol:600867) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Company, based in china. The company manufactures and sells pharmaceuticals. Its products include recombinant human insulin bulk drugs and injections, zhennaoning capsules, dongbao gantai tablets, as well ...

Adocia (ADOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adocia (ADOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Infection. It has completed phases i and ii studies of the formulation of fast-acting human insulin, phases i and ii studies of an ultra-fast acting insulin lispro and phase i/ii on a unique combination of insulin ...

Biomm S.A. (BIOM4) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biomm S.A. (BIOM4) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Of human insulin and other recombinant proteins. Its technology is used in the production of therapeutic proteins, such as calcitonin, interferons and growth hormones. The company offers processes ...

2014 Market Research Report on Global Insulin Industry

2014 Market Research Report on Global Insulin Industry

  • $ 2 200
  • Industry report
  • November 2014
  • by QY Research Group

... Manufactus human insulin production value market share list 24table 2009-2014 global major manufactus analogue insulin production value (million $) and total analogue production value (million $) list ...

Insulin Markets in China

Insulin Markets in China

  • $ 4 000
  • Industry report
  • September 2014
  • by Asia Market Information & Development Company

... And demandthe output and market share of animal insulin major producers china's human insulin production and demandthe output and market share of human insulin major producers china's insulin ...

Asia Pacific Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin

Asia Pacific Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin

  • $ 1 500
  • Industry report
  • September 2014
  • by Ken Research Private

... To 2018 - transition from human insulin to analog insulin' presents a comprehensive analysis of market size by value of major types of insulin consumed in asia pacific region. The report entails the market ...

India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies

India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies

  • $ 900
  • Industry report
  • September 2014
  • by Ken Research Private

... The diabetic population in india is largely treated with human insulin solely due to the fact that it is cheaper as compared to analog insulin. In fy'2013, human insulin held ~% of the total insulin market ...

China Insulin Market Review to 2018 - Increasing Focus on R&D Investments

China Insulin Market Review to 2018 - Increasing Focus on R&D Investments

  • $ 900
  • Industry report
  • September 2014
  • by Ken Research Private

... Of analog insulin was usd ~ million, whereas that of human insulin was usd ~ million.The government of china is actively involved in resisting the problems related to the increasing prevalence of diabetes ...

About 200 reports for Human Insulin

Download Unlimited Documents from Trusted Public Sources

Novo Nordisk Annual Report 2013

  • January 2013
    116 pages
  • Diabete  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.